Skip to content

Using GLP-1s

Reading your DXA results over time: tracking fat vs. lean mass on a GLP-1

Your second DXA report is only useful if you can tell real change from measurement noise. This guide shows how to read the key numbers over time (fat mass, lean mass, body fat %, visceral fat, bone density), what a good GLP-1 trajectory looks like, why small changes may be noise, and how to shift the fat-to-lean loss ratio.

By the glp1.how editorial teamReviewed 5 min read

Evidence-backed

You got the baseline scan, you did the work, and now the second report is in your hands: two columns of numbers that are supposed to tell you whether the last few months went the way you hoped. The trick is knowing which of those numbers actually moved, and which just wobbled.

If you haven't had your first scan yet, start with our companion guide on getting a DXA scan and what it measures. This one picks up afterward: how to read a report against your last one and tell real change from measurement noise.

The numbers that matter, and what "better" looks like

A DXA report hands you more figures than you need. The ones worth watching over time are:

  • Total mass: your weight, the same number the scale gives you, and the least informative one here.
  • Fat mass: total fat in kilograms or pounds, plus a breakdown by region (arms, legs, trunk). This is the number you most want to see fall.
  • Lean mass (sometimes labeled lean soft tissue or fat-free mass): muscle and everything else that isn't fat or bone. The number you most want to protect.
  • Body fat percentage: fat mass divided by total mass. Useful, but it can move just because one of its two inputs moved, so read it alongside the raw kilograms.
  • Visceral fat (VAT): the metabolically active fat around your organs. It's also the least precise number on the report (more on that below).
  • Bone mineral density: carried over from DXA's original job as an osteoporosis screen. It changes slowly, so don't expect meaningful movement between scans a few months apart. For what weight loss does to bone and how to protect it, see protecting your bones on a GLP-1.

On a GLP-1, a good trajectory is easy to describe and harder to achieve: fat mass down, lean mass holding as steady as you can keep it. A drop in total weight that is almost entirely fat, with lean mass barely changed, is the outcome you're training and eating for. Some lean loss alongside the fat is expected, but treat it as a signal to push harder on protein and resistance work, and don't celebrate the smaller number on the scale just yet. (One caveat if you've lost a lot of weight: loose skin is fat-free tissue that DXA files under "lean," which can flatter that number. See does loose skin throw off your DXA, BIA, or Seca results?)

The precision trap: small changes may be noise

Before you react to a single report, know how much the machine itself wobbles. DXA is precise, but not perfect. A 2026 study that scanned people twice in a row put DXA's precision error (coefficient of variation) at roughly 1% for whole-body fat mass and under 1% for fat-free mass (DOI (external link)). In practical terms, an earlier study found the repeat-scan error was around 0.5 kg for whole-body fat mass and around 0.6–0.7 kg for lean mass. It used the International Society for Clinical Densitometry method to calculate a "least significant change," the smallest difference between two scans that reflects real change and not machine variability (DOI (external link)).

So if your lean mass reads half a kilogram lower than last time, that may be noise. A change only becomes trustworthy once it clears the least-significant-change threshold, which is why the trend across three or four scans tells you far more than any single scan-to-scan difference. Regional numbers are noisier still, and visceral fat is the noisiest of all: one precision study measured a VAT error near 16%, versus about 1.4% for whole-body fat (DOI (external link)). Treat a big VAT swing as a rough direction, not a decimal-point fact.

Scan the same way every time

Because you're chasing changes that can be smaller than the machine's own error, consistency matters a lot. Two rules do most of the work:

  • Same machine, ideally the same clinic. Different DXA models don't read identically. One study found systematic differences between two densitometers large enough to require conversion equations before their numbers could be compared (DOI (external link)). A "loss" that's really just a change of scanner wastes a checkpoint.
  • Same hydration and fasting state. Lean-tissue readings partly reflect body water, so a scan after a big meal, a hard workout, or a lot of fluid will differ from a fasted, rested one. Researchers who standardized food, fluid, and activity in the 24 hours before scanning concluded it has the potential to shrink the measurement error further, though that still needs confirming (DOI (external link)). Book your scans at a similar time of day, fasted, before training, and keep that routine each time.

How much lean loss is normal, and how to shift the ratio

Some lean-mass loss is expected on a GLP-1. A 2024 review in Diabetes Care reports that incretin medications cause a rapid loss of lean mass in trials, roughly 10% or about 6 kg, which the authors compare to a decade or more of aging (DOI (external link)). So if your report shows part of the loss coming from lean tissue, you're in the expected range and you haven't failed.

What you can change is how big that share is. The same review notes that supervised resistance training lasting more than 10 weeks can add about 3 kg of lean mass and about 25% more strength, and its authors recommend tailored resistance training alongside incretin therapy to preserve lean mass while you lose fat. Pair it with adequate protein. Our guides on why strength training matters and protein, fat, and carbohydrates cover the how, and your serial DXA reports are how you confirm it's working. A lean-loss trend that flattens out once you add training and protein is exactly what these scans exist to show.

This is general education and peer information, not medical advice. Interpreting your specific results belongs with your prescriber or a clinician who can see the full report. Research findings here are drawn from PubMed; see the linked studies for details.

dxabody-compositionlean-masstracking-progressvisceral-fat

Common questions

Questions people often ask about this topic.

  • Which numbers on my DXA report should I actually track over time?

    The ones worth watching are fat mass (the number you most want to see fall), lean mass (the number you most want to protect), body fat percentage read alongside the raw kilograms, and visceral fat as a rough direction. Total mass is just your scale weight and is the least informative, and bone density changes too slowly to move meaningfully between scans a few months apart.

  • My lean mass dropped half a kilogram between scans — did I lose muscle?

    Not necessarily. Repeat-scan studies put DXA's error at around 0.5 kg for whole-body fat mass and 0.6–0.7 kg for lean mass, so a half-kilogram difference may be measurement noise. A change only becomes trustworthy once it clears the "least significant change" threshold, which is why the trend across three or four scans tells you far more than any single scan-to-scan difference.

  • How much lean mass loss is normal on a GLP-1?

    Some lean loss is expected. A 2024 review reports that incretin medications cause a lean-mass loss of roughly 10%, or about 6 kg, in trials. If part of your loss is coming from lean tissue, you're in the expected range and haven't failed. Resistance training and adequate protein are how you work to shrink that share.

  • Do I need to use the same DXA machine for every scan?

    Ideally yes: same machine, same clinic. Different DXA models don't read identically, and one study found systematic differences between two densitometers large enough to require conversion equations before their numbers could be compared. Also scan in the same hydration and fasting state each time, since lean-tissue readings partly reflect body water.

  • Is the visceral fat number on my DXA report reliable?

    It's the noisiest number on the report. One precision study measured visceral fat error near 16%, versus about 1.4% for whole-body fat, so treat a big visceral fat swing as a rough direction and not a decimal-point fact.

Evidence

The sources behind this article, labeled by type and strength.

Supporting3

Mixed findings1

Revision history

Updated 4 times since Sep 2, 2026 · show changes
  1. v5

    Evidence sources revised

  2. v4

    Common questions revised

  3. v3

    Summary rewritten; Body revised

  4. v2

    Body revised

  5. v1

    Change tracking began

Related guides

  • Does loose skin throw off your DXA, BIA, or Seca body-composition results? · Loose skin is fat-free tissue that body-composition scanners have no separate box for, so after large weight loss it can nudge your DXA "lean mass" up and your body-fat % down, and it complicates BIA and Seca readings too. This guide covers how each method (DXA, BIA/Seca, MRI) handles loose skin, how they rate for a body carrying a lot of it, and how to read your results anyway.
  • DXA scans for tracking progress on a GLP-1: what they are, how they compare to BIA, and how to get one · The scale can't tell you if you're losing fat or muscle. A DXA scan can. This guide covers what a DXA scan measures, how it compares to BIA devices like Seca and InBody (including home scales), how often to get one, and where to get scanned.
  • Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis · GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.
  • Restarting a GLP-1 after a missed stretch: what each drug's label says about re-titration · Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.
  • Comparing the GLP-1 pills: Ozempic tablets (Rybelsus), the Wegovy pill, and Foundayo · There are now three GLP-1 pills in the US, and they aren't interchangeable: oral semaglutide for diabetes (Rybelsus, now sold as Ozempic tablets), oral semaglutide for weight (the Wegovy pill), and orforglipron (Foundayo). Here's how they compare on approval, how you take them, what the trials found, side effects, cost, and what you give up versus a weekly injection.
  • Every key GLP-1 clinical trial: what it tested, who paid for it, and what it found · STEP 1, SURMOUNT-4, SELECT, LEADER: GLP-1 trial names get quoted everywhere, usually without context. This reference page lists 205 named, completed GLP-1 trials in one place, grouped by drug and by question, with what each one tested, who sponsored it, its headline result, and a link to the published paper. It also lists the trials that finished but have not reported, and shows who paid for the research.

Related terms

  • Lean mass · Body weight from everything other than fat: mostly muscle, plus organs and water, and in the broad sense bone. On a DXA report, lean mass usually leaves bone out.
  • Fat-free mass · Everything in the body that isn't fat — muscle, organs, bone, and water — measured as total body weight minus all fat mass.
  • Visceral fat · Fat stored deep in the abdomen around the internal organs, which is more strongly tied to metabolic and cardiovascular risk than fat under the skin.
  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Least significant change (DXA precision) · The minimum difference between two scans on the same machine that can be considered a true change rather than measurement error, usually reported as a percentage or in grams.
  • Incretin · A class of gut hormones, including GLP-1 and GIP, that trigger insulin release in response to food.
  • Resistance training (progressive overload) · Exercise that loads your muscles against resistance and is made gradually harder over time (progressive overload) to keep or build muscle and strength.

Was this helpful?

Improve this page